Drawing for TUBLIGIN

USPTO serial 79154863

TUBLIGIN

Reviewed by CopyMark Law Group

Reg. 4737231Status 404
Filing date
Status date
Registration date
May 19, 2015
Examiner
MALASHEVICH, JASON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TUBLIGIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; vaccines; diagnostic preparations for medical purposesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 8, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 30, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 15, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 15, 2015FIMPFINAL DISPOSITION PROCESSED—
Aug 19, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 19, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 3, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2015GPNXNOTIFICATION PROCESSED BY IB—
Feb 11, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 11, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 28, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 28, 2015ALIEASSIGNED TO LIE—
Jan 8, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 30, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 30, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 30, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2014RFNTREFUSAL PROCESSED BY IB—
Dec 17, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 26, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 26, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 25, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2014DOCKASSIGNED TO EXAMINER—
Nov 18, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 14, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 13, 2014SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance